148 related articles for article (PubMed ID: 10682487)
21. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.
Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T
Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189
[TBL] [Abstract][Full Text] [Related]
22. [Mutations of p53 gene exons 5 to 8 in human ovarian cancer and its clinical significance].
You Z; Guo Y; Wen H
Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):660-3. PubMed ID: 9387525
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of mutation types of p53 gene and possible carcinogenic factors in lung cancer].
Gao ZQ; Gao Z; Zhang X
Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Mar; 31(2):88-91. PubMed ID: 9812619
[TBL] [Abstract][Full Text] [Related]
24. [Mutations of the p53 suppressor gene in gastric adenocarcinoma].
Aranda M; Náquira N; Karque R; Mendoza H; Sepúlveda C; Silva C
Rev Med Chil; 1998 May; 126(5):525-32. PubMed ID: 9731434
[TBL] [Abstract][Full Text] [Related]
25. [High frequency mutation of p53 gene in human gastric cancer and precancerous lesions].
Li Z; Lü Y
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):90-3. PubMed ID: 10920952
[TBL] [Abstract][Full Text] [Related]
26. p53 gene mutation analysis and antisense-mediated growth inhibition of human ovarian carcinoma cell lines.
Skilling JS; Squatrito RC; Connor JP; Niemann T; Buller RE
Gynecol Oncol; 1996 Jan; 60(1):72-80. PubMed ID: 8557231
[TBL] [Abstract][Full Text] [Related]
27. [The status of p53 gene in the primary retinoblastoma].
Huang Q
Zhonghua Yan Ke Za Zhi; 1999 Jul; 35(4):248-51. PubMed ID: 11835813
[TBL] [Abstract][Full Text] [Related]
28. Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease.
Kupryjanczyk J; Thor AD; Beauchamp R; Poremba C; Scully RE; Yandell DW
Mod Pathol; 1996 Mar; 9(3):166-73. PubMed ID: 8685209
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of types of P53 gene mutation in gastric cancer tissues].
Gao Z; Gao Z; Liu X
Zhonghua Yu Fang Yi Xue Za Zhi; 1996 Nov; 30(6):343-6. PubMed ID: 9388909
[TBL] [Abstract][Full Text] [Related]
30. [p53 gene mutation determined by single-strand conformational polymorphism and DNA sequencing analysis in pleomorphic adenoma of salivary gland].
Wang J; Dong F; Yong P
Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):298-300. PubMed ID: 11776898
[TBL] [Abstract][Full Text] [Related]
31. Is it possible to diagnose malignancy from fluid in cystic ovarian tumors?
Yamada R; Maeda N; Oguri H; Adachi Y; Takeuchi T; Furihata M; Fukaya T
Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):96-100. PubMed ID: 24017961
[TBL] [Abstract][Full Text] [Related]
32. Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma.
Lianidou ES; Levesque MA; Katsaros D; Angelopoulou K; Yu H; Genta F; Arisio R; Massobrio M; Bharaj B; Diamandis EP
Anticancer Res; 1999; 19(1B):749-56. PubMed ID: 10216487
[TBL] [Abstract][Full Text] [Related]
33. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan.
Chen FM; Hou MF; Wang JY; Chen TC; Chen DC; Huang SY; Chung YS; Lin SR
Cancer Lett; 2004 Apr; 207(1):59-67. PubMed ID: 15050734
[TBL] [Abstract][Full Text] [Related]
34. p53 and bcl-2 in epithelial ovarian carcinoma: their value as prognostic indicators at a median follow-up of 60 months.
Geisler JP; Geisler HE; Miller GA; Wiemann MC; Zhou Z; Crabtree W
Gynecol Oncol; 2000 May; 77(2):278-82. PubMed ID: 10785478
[TBL] [Abstract][Full Text] [Related]
35. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
[TBL] [Abstract][Full Text] [Related]
36. p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer.
Dong M; Nio Y; Yamasawa K; Toga T; Yue L; Harada T
J Surg Oncol; 2003 Feb; 82(2):111-20. PubMed ID: 12561067
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ
Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416
[TBL] [Abstract][Full Text] [Related]
38. [The research on p53 gene mutation in lung cancer tissue of silicotic patients by PCR-SSCR].
Zhou P; Liu B; Miao Q; Wang H
Wei Sheng Yan Jiu; 1997 Sep; 26(5):293-5, 298. PubMed ID: 10325639
[TBL] [Abstract][Full Text] [Related]
39. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.
Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL
Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of genetic instability of nm23H1 gene to clinicopathologic features of epithelial ovarian carcinoma].
Yang YQ; Li JC
Ai Zheng; 2006 Jun; 25(6):713-7. PubMed ID: 16764766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]